The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared with placebo atop standard care (annualized rate 1.11 vs 1.31, P =0.049), ...

Among 650 kids who were at least age 2 years, and had at least one well-child visit, less than one-fifth had a previous ...

While the use of AI in health insurance isn't new, Medicare has been slow to adopt the private-sector tools. Medicare has historically used prior authorization in a limited way, with contractors who ...

For all adults, excessive alcohol use is a leading preventable cause of death in the U.S. with over 178,000 deaths annually.

Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS ...

Among the creators who have been banned from YouTube under the now-expired policies are prominent conservative influencers, ...

Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial ...